Status:
UNKNOWN
Impact of Antichlamydial Treatment on the Rate of Preeclampsia
Lead Sponsor:
Ain Shams Maternity Hospital
Conditions:
Pre-Eclampsia
Eligibility:
FEMALE
18-35 years
Phase:
PHASE4
Brief Summary
This randomized, double blinded controlled trial included 1200 healthy primigravidae who attended an outpatient clinic at 16-20weeks of pregnancy. All women were randomly divided equally into two grou...
Detailed Description
Preeclampsia complicates approximately 5-8% of all pregnancies and is a major cause of maternal morbidity and mortality worldwide.Its progress differs among patients; most cases are diagnosed pre-term...
Eligibility Criteria
Inclusion
- primigravida, singleton pregnancy, maternal age 18-35 years, and pregnancy duration 16-20 weeks at the time of study inclusion.
Exclusion
- Women with multi-fetal pregnancy, diabetes mellitus, chronic hypertension, or chronic renal disease
Key Trial Info
Start Date :
July 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2018
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT03233880
Start Date
July 1 2016
End Date
August 1 2018
Last Update
June 28 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University Maternity Hospital
Cairo, Egypt